Publicaciones en las que colabora con José Juan García Marín (7)

2024

  1. Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events

    Journal of Hepatology

  2. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

2022

  1. Impact of alternative splicing variants on liver cancer biology

    Cancers, Vol. 14, Núm. 1

2021

  1. Impact of alternative splicing on mechanisms of resistance to anticancer drugs

    Biochemical Pharmacology, Vol. 193

2020

  1. Molecular bases of drug resistance in hepatocellular carcinoma

    Cancers, Vol. 12, Núm. 6, pp. 1-26

  2. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5

2019

  1. What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 15, Núm. 7, pp. 577-593